Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Atopic Dermatitis Excellence Forum

Amy S Paller, MD
Videos
01/04/2022
In this video, Amy S Paller, MD, discusses the benefits of Investigator Global Assessment and affected body surface area as alternatives to EASI and SCORAD.
In this video, Amy S Paller, MD, discusses the benefits of Investigator Global Assessment and affected body surface area as alternatives to EASI and SCORAD.
In this video, Amy S Paller, MD,...
01/04/2022
The Dermatologist
NEA Approved Features
12/08/2021
Jessica Garlewicz, Associate Digital Editor
A recently published study found that patients with atopic dermatitis treated with dupilumab experienced less severe COVID-19 symptoms compared with other treatments.
A recently published study found that patients with atopic dermatitis treated with dupilumab experienced less severe COVID-19 symptoms compared with other treatments.
A recently published study found...
12/08/2021
The Dermatologist
Robert Sidbury, MD, MPH
Videos
11/29/2021
In this video, Dr Robert Sidbury discusses how dermatologists can create an effective eczema care plan that is easy to use and understand by patients and caregivers.
In this video, Dr Robert Sidbury discusses how dermatologists can create an effective eczema care plan that is easy to use and understand by patients and caregivers.
In this video, Dr Robert Sidbury...
11/29/2021
The Dermatologist
Naimish Patel, MD, head of global development, immunology and inflammation at Sanofi Genzyme discussed atopic dermatitis.
Q&As
11/15/2021
The results of a pivotal phase 3 trial of dupilumab brings updates in treating children aged 6 months to 5 years with moderate to severe atopic dermatitis.
The results of a pivotal phase 3 trial of dupilumab brings updates in treating children aged 6 months to 5 years with moderate to severe atopic dermatitis.
The results of a pivotal phase 3...
11/15/2021
The Dermatologist
Dr Olayemi Sokumbi, a dermatologist and dermatopathologist, shared dupilumab’s impact on atopic dermatitis and skin cancer.
Q&As
09/29/2021
In this exclusive interview, Dr Olayemi Sokumbi discussed her recent study, “Evolution of Dupilumab-Associated Cutaneous Atypical Lymphoid Infiltrates.”
In this exclusive interview, Dr Olayemi Sokumbi discussed her recent study, “Evolution of Dupilumab-Associated Cutaneous Atypical Lymphoid Infiltrates.”
In this exclusive interview, Dr...
09/29/2021
The Dermatologist
Dr Peter Lio, an expert on atopic dermatitis, shares what’s down the pipeline for pediatric atopic dermatitis treatment.
Videos
09/28/2021
In this video, Dr Peter Lio discussed emerging therapeutics and his insights on future care for pediatric patients with AD.
In this video, Dr Peter Lio discussed emerging therapeutics and his insights on future care for pediatric patients with AD.
In this video, Dr Peter Lio...
09/28/2021
The Dermatologist
Marc Serota, MD, is an expert on asthma, dermatology procedure-related injuries, vaccine-related injuries, and more.
Q&As
09/10/2021
In this interview, Marc Serota, MD, discusses updates on dupilumab’s impact on asthma and sinonasal conditions, particularly for patients with atopic dermatitis.
In this interview, Marc Serota, MD, discusses updates on dupilumab’s impact on asthma and sinonasal conditions, particularly for patients with atopic dermatitis.
In this interview, Marc Serota,...
09/10/2021
The Dermatologist
Dr Raj Chovatiya, one of the leading experts in atopic dermatitis a form of eczema in dermatology
Videos
08/30/2021
In this video Dr Raj Chovatiya, one of the leading experts in atopic dermatitis, discusses frequently updated literature surrounding AD treatment and patient quality of life.
In this video Dr Raj Chovatiya, one of the leading experts in atopic dermatitis, discusses frequently updated literature surrounding AD treatment and patient quality of life.
In this video Dr Raj Chovatiya,...
08/30/2021
The Dermatologist
NEA Approved Features
08/16/2021
Lauren Mateja, Managing Editor
Patients with atopic dermatitis and complex treatment regimens are at an increased risk of complications or ill effects, known as iatrogenic burden. Dr Raj Chovatiya explains what dermatologists should know about iatrogenic burden and how to...
Patients with atopic dermatitis and complex treatment regimens are at an increased risk of complications or ill effects, known as iatrogenic burden. Dr Raj Chovatiya explains what dermatologists should know about iatrogenic burden and how to...
Patients with atopic dermatitis...
08/16/2021
The Dermatologist
silverberg
Q&As
08/10/2021
Jonathan Silverberg, MD, PhD, MPH, met with The Dermatologist to share his insights on atopic dermatitis prior to his session on the topic at the AAD Summer Meeting 2021.
Jonathan Silverberg, MD, PhD, MPH, met with The Dermatologist to share his insights on atopic dermatitis prior to his session on the topic at the AAD Summer Meeting 2021.
Jonathan Silverberg, MD, PhD,...
08/10/2021
The Dermatologist

Advertisement

Advertisement

Advertisement